Atara Biotherapeutics Inc... (ATRA)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

10.33

-0.29%

After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Revenue	8.57M	63.57M	20.34M	-	-	-	-	-	-	-	-	-
Cost of Revenue	8.89M	14.57M	11.38M	9.87M	8.11M	3.78M	956.00K	383.00K	48.00K	-	-	-
Gross Profit	-313.00K	49.01M	8.96M	-9.87M	-8.11M	-3.78M	-956.00K	-383.00K	-48.00K	-	-	-
Operating Income	-276.01M	-280.51M	-340.46M	-309.05M	-295.68M	-237.11M	-121.53M	-81.24M	-58.45M	-28.16M	-8.62M	-3.23M
Interest Income	5.43M	1.99M	367.00K	2.45M	4.72M	6.37M	2.03M	2.20M	1.22M	125.00K	12.00K	-
Pretax Income	-276.11M	-228.29M	-340.10M	-306.61M	-290.96M	-230.74M	-119.50M	-79.04M	-57.23M	-28.03M	-8.60M	-12.28M
Net Income	-276.13M	-2.28B	-3.40B	-3.07B	-2.91B	-2.31B	-1.19B	-790.49M	-572.21M	-280.06M	-87.73M	-123.30M
Selling & General & Admin	49.80M	71.55M	78.80M	64.40M	79.58M	69.65M	40.33M	24.73M	16.83M	12.71M	3.76M	2.50M
Research & Development	224.78M	272.53M	282.00M	244.65M	216.10M	167.46M	81.21M	56.51M	41.62M	15.45M	4.86M	9.78M
Other Expenses	-	-700.00K	-	-	-	-	-	-	-	1.07M	-	-
Operating Expenses	275.69M	344.09M	360.80M	309.05M	295.68M	237.11M	121.53M	81.24M	58.45M	28.16M	8.62M	12.28M
Interest Expense	5.29M	1.99M	-	-	-	-	-	-	-	-	-	-
Selling & Marketing Expenses	-1.11M	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	284.58M	344.09M	360.80M	309.05M	295.68M	237.11M	121.53M	81.24M	58.45M	28.16M	8.62M	12.28M
Income Tax	15.00K	12.00K	46.00K	15.00K	12.00K	-44.00K	-14.00K	10.00K	-9.00K	-25.00K	170.00K	51.00K
Shares Outstanding (Basic)	4.24M	4.08M	3.75M	2.96M	2.05M	1.75M	1.19M	1.15M	1.02M	199.44K	38.63K	733.29K
Shares Outstanding (Diluted)	4.24M	4.08M	3.75M	2.96M	2.05M	1.75M	1.19M	1.15M	1.02M	199.44K	38.63K	733.29K
EPS (Basic)	-65.18	-55.96	-90.78	-103.63	-141.78	-131.64	-100.03	-68.78	-55.92	-140.42	-227.09	-16.81
EPS (Diluted)	-65.18	-55.96	-90.78	-103.63	-141.78	-131.64	-100.03	-68.78	-55.92	-140.42	-227.09	-16.81
EBITDA	-266.00M	-213.72M	-331.12M	-296.74M	-282.86M	-233.33M	-120.58M	-80.86M	-58.40M	-28.15M	-8.61M	-4.09M
Depreciation & Amortization	4.83M	14.57M	11.38M	9.87M	8.11M	3.78M	956.00K	383.00K	48.00K	6.00K	4.00K	3.23M